JP2010516817A5 - - Google Patents

Download PDF

Info

Publication number
JP2010516817A5
JP2010516817A5 JP2009548391A JP2009548391A JP2010516817A5 JP 2010516817 A5 JP2010516817 A5 JP 2010516817A5 JP 2009548391 A JP2009548391 A JP 2009548391A JP 2009548391 A JP2009548391 A JP 2009548391A JP 2010516817 A5 JP2010516817 A5 JP 2010516817A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
formula
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009548391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010516817A (ja
JP5566692B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/052318 external-priority patent/WO2008094912A2/en
Publication of JP2010516817A publication Critical patent/JP2010516817A/ja
Publication of JP2010516817A5 publication Critical patent/JP2010516817A5/ja
Application granted granted Critical
Publication of JP5566692B2 publication Critical patent/JP5566692B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009548391A 2007-01-31 2008-01-29 治療薬としての置換ガンマラクタム類 Expired - Fee Related JP5566692B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88741507P 2007-01-31 2007-01-31
US60/887,415 2007-01-31
PCT/US2008/052318 WO2008094912A2 (en) 2007-01-31 2008-01-29 Substituted gamma lactams as therapeutic agents

Publications (3)

Publication Number Publication Date
JP2010516817A JP2010516817A (ja) 2010-05-20
JP2010516817A5 true JP2010516817A5 (cg-RX-API-DMAC7.html) 2011-03-10
JP5566692B2 JP5566692B2 (ja) 2014-08-06

Family

ID=39639429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009548391A Expired - Fee Related JP5566692B2 (ja) 2007-01-31 2008-01-29 治療薬としての置換ガンマラクタム類

Country Status (11)

Country Link
US (1) US7960381B2 (cg-RX-API-DMAC7.html)
EP (1) EP2121672B1 (cg-RX-API-DMAC7.html)
JP (1) JP5566692B2 (cg-RX-API-DMAC7.html)
KR (1) KR101561706B1 (cg-RX-API-DMAC7.html)
CN (1) CN101595106B (cg-RX-API-DMAC7.html)
AU (1) AU2008210559B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0808377B8 (cg-RX-API-DMAC7.html)
CA (1) CA2676291C (cg-RX-API-DMAC7.html)
MX (1) MX2009008039A (cg-RX-API-DMAC7.html)
NZ (1) NZ578698A (cg-RX-API-DMAC7.html)
WO (1) WO2008094912A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377984B2 (en) * 2008-01-29 2013-02-19 Allergan, Inc. Substituted gamma lactams as therapeutic agents
BRPI0910741A2 (pt) * 2008-04-24 2015-09-29 Allergan Inc arilciclopentenos substituídos como agonistas de prostaglantina ep2
BRPI0911406A2 (pt) * 2008-04-24 2015-10-06 Allergan Inc gama lactames substituídos como agentes terapêuticos
CN102076681A (zh) * 2008-04-24 2011-05-25 阿勒根公司 作为治疗剂的取代γ-内酰胺
JP2011520811A (ja) * 2008-05-09 2011-07-21 アラーガン インコーポレイテッド 治療用の置換チアゾリジノン類、オキサゾリジノン類および関連化合物
AU2009249388B2 (en) * 2008-05-20 2014-04-03 Allergan, Inc. Therapeutic lactams

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211201A (pt) * 2001-07-16 2004-07-13 Hoffmann La Roche Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero
BR0213911A (pt) * 2001-11-05 2004-09-28 Allergan Inc Análogos de Èmega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas do receptor ep2
RU2306309C2 (ru) * 2002-03-05 2007-09-20 Оно Фармасьютикал Ко., Лтд. Производное 8-азапростагландина, фармацевтическая композиция, агент для профилактики заболеваний
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
EP1556347A4 (en) * 2002-06-10 2006-08-09 Applied Research Systems GAMMA LACTAME AS PROSTAGLAND INAGONISTS AND THEIR USE
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
PL1856042T3 (pl) * 2005-03-10 2012-11-30 Allergan Inc Podstawione gamma laktamy jako środki terapeutyczne
WO2007109578A2 (en) * 2006-03-20 2007-09-27 Allergan, Inc. Substituted gamma lactams as prostaglandin ep2 agonists

Similar Documents

Publication Publication Date Title
WO2006098918B1 (en) Substituted gamma lactams as therapeutic agents
JP2010516817A5 (cg-RX-API-DMAC7.html)
JP2010524932A5 (cg-RX-API-DMAC7.html)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2005112864A5 (cg-RX-API-DMAC7.html)
JP2010077141A5 (cg-RX-API-DMAC7.html)
JP2007533740A5 (cg-RX-API-DMAC7.html)
JP2011509309A5 (cg-RX-API-DMAC7.html)
JP2011504903A5 (cg-RX-API-DMAC7.html)
JP2013542247A5 (cg-RX-API-DMAC7.html)
JP2011516511A5 (cg-RX-API-DMAC7.html)
JP2007517846A5 (cg-RX-API-DMAC7.html)
JP2005539088A5 (cg-RX-API-DMAC7.html)
JP2014521744A5 (cg-RX-API-DMAC7.html)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
JP2010523476A5 (cg-RX-API-DMAC7.html)
JP2009543795A5 (cg-RX-API-DMAC7.html)
JP2007302689A5 (cg-RX-API-DMAC7.html)
JP2013544860A5 (cg-RX-API-DMAC7.html)
JP2011512412A5 (cg-RX-API-DMAC7.html)
JP2013500342A5 (cg-RX-API-DMAC7.html)
JP2017511368A5 (cg-RX-API-DMAC7.html)
JP2014505723A5 (cg-RX-API-DMAC7.html)
JP2011509302A5 (cg-RX-API-DMAC7.html)
JP2004502732A5 (cg-RX-API-DMAC7.html)